Content on PharmTech.com this week ranged from fundamentals on the use of digital pathology in drug development, discussions on the use of AI in pharma, and regulatory actions impacting the industry.
|Webcasts|September 19, 2019
From Basics to Best Practices: Exploring Bioassays and Binding Assays
Author(s)Catalent
This webcast will describe one solution: Working with a clinical supply partner to handle the packaging and potential complex distribution logistics for expanded access programs and commercial supply. Live: Thursday, Sept. 19, 2019 10am EDT | 9am CDT | 3pm BST | 4pm CEST On demand available after airing until Sept. 19, 2020 Register free
Register free:
Event Overview:
Biologics analytical testing is rapidly evolving as new testing protocols become available and companies seek to expedite current methodologies. Learn about the latest cell-based bioassays and binding assays, including applications, advancements, and outlook. The discussion will focus on a variety of assays including antibody-dependent cellular cytotoxicity, Octet, AlphaLISA, and Host Cell Protein (HCP), as well as the potential application of automation.
In this webcast, a panel of four industry experts will unravel the science and dive into some specific applications, providing useful information for both novices and experts. The presentation will be followed by a roundtable discussion, where the panel will discuss registrant-submitted questions and address current issues and trends within bioassays and binding assays.
Register now to submit a question for the experts!
Key Learning Objectives:
- Fundamentals on how various assays work, when they should be used and what questions they answer
- Differences between various bioassays and binding assay
- Application of immunochemistry-based platform technologies to analyses of biologics
Speakers: Michael Sadick, PhD, Principal Scientist, Biologics Analytical Development, Catalent
Dan Papa, PhD, Group Leader, Biologics, Catalent
Eric S. Bishop, Vice President of Research & Development, Cygnus Technologies, LLC
Jeff Dixon, Field Application Scientist, PerkinElmer
Time and date: Thursday, Sept. 19, 2019 10am EDT | 9am CDT | 3pm BST | 4pm CEST
On demand available after airing until Sept. 19, 2020
Sponsor: Catalent
Register free:
Related to this article
This article discusses risk-based lifecycle governance, system implementation considerations, and the progression of batch record control from paper-based to fully electronic systems.
Ronald Piervincenzi, USP, explains why manufacturers should act now and how benchmarking could reward reliable generic drug suppliers.
The FDA approves Lilly's once-weekly insulin efsitora for type 2 diabetes, raising Fc-fusion manufacturing, high-concentration pen, and capacity questions.
Florin Muraru, Gourav Pandey, and Richard Jaenisch explain where human sign-off belongs as multi-agent AI and document-parsing models reach GxP.
In this episode of Ask the Expert, Siegfried Schmitt, PhD, vice president, Technical at Parexel, and Susan J. Schniepp, distinguished fellow at Nelson Labs, discuss how companies should approach post-approval changes to their CMC regulatory filings.
The EC has approved AstraZeneca's Trixeo Aerosphere as the first single-inhaler triple-combination therapy for asthma in the EU, based on phase e data showing improved lung function and fewer severe exacerbations in patients uncontrolled on standard ICS/LABA treatment.
In this episode of Pharma Fundamentals, Dr. Aleksandra Zuraw, senior veterinary pathologist at Charles River, provides an introduction to the use of digital pathology in drug development.
Trending on Pharmaceutical Technology
1
Pharma Fundamentals: Digital Pathology in Drug Development, Part 1
2
EU Clears AstraZeneca's Trixeo for Asthma, Opening New Manufacturing Demand for Single-Inhaler Triple Therapy
3
PharmTech’s Weekly Roundup—September 25, 2026
4
Risk-Based Life Cycle Management of Master Production and Control Records to Strengthen Data Integrity and GMP Inspection Readiness Part 2: Practical Considerations for CGMP Documentation Systems
5